High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
about
Identification of a three-gene expression signature of poor-prognosis breast carcinomaEstrogen signaling and the DNA damage response in hormone dependent breast cancers.Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survivalBRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.High expression of PALB2 predicts poor prognosis in patients with advanced breast cancer.
P2860
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@ast
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@en
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@nl
type
label
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@ast
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@en
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@nl
prefLabel
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@ast
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@en
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@nl
P2093
P2860
P356
P1476
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
@en
P2093
Chiyomi Egawa
Shinzaburo Noguchi
Tetsuya Taguchi
Yasuhiro Tamaki
Yasuo Miyoshi
P2860
P304
P356
10.1002/IJC.10231
P577
2002-04-01T00:00:00Z